Efficacy of DA-5204 on Gastroesophageal Reflux Disease

Summary

This is a single-center, randomized, double-blind, placebo-controlled clinical Study to evaluate the efficacy of DA-5204 and proton pump inhibitor combination therapy compared with proton pump inhibitor alone therapy in patients with gastroesophageal reflux Disease.

Timeline

Start

2016-06-01

Primary completion

2018-12-11

Completion

2018-12-11

Drugs

Indications